NCT01677247 - Bioequivalence Study of 4 mg Glimepiride Tablet | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions

Glimepiride BE Study in Healthy Volunteers Under Fasting Condition

Interventions

DRUG

Group I (Test) : Glimepiride 4 mg tablet of PT Dexa Medica

In each of the two study periods (separated by a washout of one week) a single dose of test or reference product was administered.

DRUG

Group II (Reference) : glimepiride (Amaryl) 4 mg tablet of PT Sanofi Aventis

In each of the two study periods (separated by a washout of one week) a single dose of test or reference product was administered.

Trial Locations (1)

PT Equilab International, Jakarta